Iffat Tameez, MD
Family Medicine · Memphis, TNNPI 1396854493
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Travere Therapeutics, Inc. at 27.6% of the total. Reporting peaked in 2022 at $187 and has fallen 84.9% since, to $28 in 2025. That places this record below the midpoint for family medicine clinicians in TN, where the typical reported total is $470.
Across 26 payments — averaging $23.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$169
- OPKO Pharmaceuticals, LLC$78
- Teva Pharmaceuticals USA, Inc.$63
- Otsuka America Pharmaceutical, Inc.$55
- AstraZeneca$50
- Akebia Therapeutics Inc$49
- plus $148 from 5 others
What the payments were for
- Food & beverage$59998%
- Education$122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$612 in reported general payments places this provider in the 50th percentile of 2,087 family medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 15 | $28,873 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $571 |
| Atorvastatin Calcium | 42 | $447 |
| Quetiapine Fumarate | 13 | $342 |
| Omeprazole | 29 | $293 |
| Amlodipine Besylate | 65 | $193 |
| Alprazolam | 25 | $191 |
| Levothyroxine Sodium | 12 | $176 |
| Pantoprazole Sodium | 12 | $172 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $165 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $162 |
| Losartan Potassium | 20 | $139 |
| Phenytoin Sodium Extended | 11 | $121 |
| Carvedilol | 16 | $115 |
| Azithromycin | 20 | $96 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Memphis
- Michael WallaceMemphis$16K
- Jay SmithMemphis$14K
- Kevin DennisFranklin$354K
- Charolette JacksonBartlett$162K
- Keren HolmesNashville$58K
- Kabir Harricharan SinghNewport$49K
- Khaisha GistAntioch$49K
- Jerry PunchKnoxville$45K
- Christopher HollowayAntioch$41K
- Curtis JantziKingsport$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.